Biodesix [BDSX] vs Danaher [DHR] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Biodesix Inc. wins in 5 metrics, Danaher Corporation wins in 13 metrics, with 0 ties. Danaher Corporation appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Biodesix Inc. | Danaher Corporation | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 34.61 | N/A |
| Price-to-Book Ratio | -34.62 | 2.40 | Danaher Corporation |
| Debt-to-Equity Ratio | -30.44 | 37.17 | Danaher Corporation |
| PEG Ratio | -47.73 | 3.84 | Danaher Corporation |
| EV/EBITDA | -6.98 | 17.69 | Danaher Corporation |
| Profit Margin (TTM) | -39.85% | 14.89% | Danaher Corporation |
| Operating Margin (TTM) | -6.84% | 22.94% | Danaher Corporation |
| EBITDA Margin (TTM) | N/A | 22.94% | N/A |
| Return on Equity | -383.09% | 7.08% | Danaher Corporation |
| Return on Assets (TTM) | -18.79% | 4.19% | Danaher Corporation |
| Free Cash Flow (TTM) | $-23.67M | $5.26B | Danaher Corporation |
| Dividend Yield | N/A | 0.56% | N/A |
| 1-Year Return | 170.20% | -3.81% | Biodesix Inc. |
| Price-to-Sales Ratio (TTM) | 1.20 | 5.10 | Biodesix Inc. |
| Enterprise Value | $154.23M | $140.38B | Danaher Corporation |
| EV/Revenue Ratio | 1.74 | 5.67 | Biodesix Inc. |
| Gross Profit Margin (TTM) | 83.03% | 60.34% | Biodesix Inc. |
| Revenue per Share (TTM) | $12 | $35 | Danaher Corporation |
| Earnings per Share (Diluted) | $-4.67 | $5.16 | Danaher Corporation |
| Beta (Stock Volatility) | 0.57 | 0.99 | Biodesix Inc. |
| Short % of Float | 3.22% | 1.10% | Danaher Corporation |
Biodesix Inc. vs Danaher Corporation Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Biodesix Inc. | 4.27% | 8.71% | 42.86% | 3.87% | 97.79% | 149.23% |
| Danaher Corporation | 1.12% | 2.86% | 2.32% | -12.71% | -22.05% | -22.71% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Biodesix Inc. | 170.20% | -39.56% | -94.00% | -93.44% | -93.44% | -93.44% |
| Danaher Corporation | -3.81% | -12.18% | -14.95% | 176.52% | 423.71% | 744.91% |
Performance & Financial Health Analysis: Biodesix Inc. vs Danaher Corporation
| Metric | BDSX | DHR |
|---|---|---|
| Market Information | ||
| Market Cap | $107.54M | $126.39B |
| Market Cap Category | Micro cap | Large cap |
| 10 Day Avg. Volume | 55,301 | 5,174,666 |
| 90 Day Avg. Volume | 66,907 | 4,357,215 |
| Last Close | $16.10 | $178.08 |
| 52 Week Range | $5.00 - $20.21 | $160.93 - $242.80 |
| % from 52W High | -20.34% | -26.66% |
| All-Time High | $31.99 (Jan 18, 2021) | $296.06 (Sep 06, 2021) |
| % from All-Time High | -49.67% | -39.85% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.41% | 0.04% |
| Quarterly Earnings Growth | 0.41% | 0.08% |
| Financial Health | ||
| Profit Margin (TTM) | -0.40% | 0.15% |
| Operating Margin (TTM) | -0.07% | 0.23% |
| Return on Equity (TTM) | -3.83% | 0.07% |
| Debt to Equity (MRQ) | -30.44 | 37.17 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-0.30 | $74.32 |
| Cash per Share (MRQ) | $1.93 | $8.06 |
| Operating Cash Flow (TTM) | $-23,271,000 | $6.44B |
| Levered Free Cash Flow (TTM) | $-11,825,250 | $4.57B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.56% |
| Last 12-Month Dividend | N/A | $1.28 |
Valuation & Enterprise Metrics Analysis: Biodesix Inc. vs Danaher Corporation
| Metric | BDSX (Apr 26, 2026) | DHR (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 34.61 |
| Forward P/E | -47.73 | 19.64 |
| PEG Ratio | -47.73 | 3.84 |
| Price to Sales (TTM) | 1.20 | 5.10 |
| Price to Book (MRQ) | -34.62 | 2.40 |
| Market Capitalization | ||
| Market Capitalization | $107.54M | $126.39B |
| Enterprise Value | $154.23M | $140.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.74 | 5.67 |
| Enterprise to EBITDA | -6.98 | 17.69 |
| Risk & Other Metrics | ||
| Beta | 0.57 | 0.99 |
| Book Value per Share (MRQ) | $-0.30 | $74.32 |
Financial Statements Comparison: Biodesix Inc. vs Danaher Corporation
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | BDSX (2025) | DHR (2025) |
|---|---|---|
| Revenue/Sales | 88.50M | 24.57B |
| Cost of Goods Sold | 16.72M | 10.05B |
| COGS % of Revenue | 18.9% | 40.9% |
| Gross Profit | 71.78M | 14.52B |
| Gross Margin | 81.1% | 59.1% |
| Research & Development | 12.00M | 1.60B |
| Operating Income (EBIT) | -27.77M | 4.69B |
| Operating Margin | -31.4% | 19.1% |
| EBITDA | -21.56M | 7.17B |
| EBITDA Margin | -24.4% | 29.2% |
| Pre-Tax Income | -35.27M | 4.23B |
| Pre-Tax Income % of Revenue | -39.8% | 17.2% |
| Income Tax | N/A | 633.00M |
| Income Tax % of Revenue | 0.0% | 2.6% |
| Net Income (Profit) | -35.27M | 3.61B |
| Profit Margin | -39.8% | 14.7% |
Balance Sheet & Liquidity Metrics
| Metric | BDSX (2025) | DHR (2025) |
|---|---|---|
| Cash & Equivalents | 18.99M | 4.62B |
| Total Current Assets | 32.52M | 12.76B |
| Total Current Assets % of Revenue | 36.7% | 51.9% |
| Total Current Liabilities | 17.44M | 6.81B |
| Total Current Liabilities % of Revenue | 19.7% | 27.7% |
| Long-Term Debt | 71.48M | 19.50B |
| Long-Term Debt % of Revenue | 80.8% | 79.4% |
| Total Shareholders Equity | -2.47M | 52.54B |
| Retained Earnings | -497.76M | 46.89B |
| Retained Earnings % of Revenue | -562.4% | 190.9% |
| Property, Plant & Equipment | 9.42M | 2.14B |
Cash Flow Statement Comparison
| Metric | BDSX (2025) | DHR (2025) |
|---|---|---|
| Operating Cash Flow | -25.70M | 5.64B |
| Operating Cash Flow % of Revenue | -29.0% | 23.0% |
| Capital Expenditures | -259,000 | -1.12B |
| Free Cash Flow | -23.67M | 5.26B |
| FCF Margin | -26.8% | 21.4% |
| Debt Repayment | -21,000 | -500.00M |
| Common Stock Repurchase | N/A | -3.09B |
Short Interest & Institutional Ownership Analysis
| Metric | BDSX | DHR |
|---|---|---|
| Shares Short | 181,818 | 6.94M |
| Short Ratio | 1.46 | 1.68 |
| Short % of Float | 3.22% | 1.10% |
| Shares Outstanding | 8.25M | 707.70M |
| Float Shares | 5.95M | 630.65M |
| % Held by Insiders | 43.11% | 10.78% |
| % Held by Institutions | 22.21% | 85.08% |
| % Held by Public | 34.68% | 4.14% |
Dividend Analysis & Yield Comparison: Biodesix Inc. vs Danaher Corporation
| Metric | BDSX | DHR |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.28 |
| Last 12-Month Dividend Yield | N/A | 0.56% |
| 3-Year Avg Annual Dividend | N/A | $10.51 |
| 3-Year Avg Dividend Yield | N/A | 1.11% |
| 3-Year Total Dividends | N/A | $31.54 |
| Ex-Dividend Date | N/A | Dec 26, 2025 |